# Why Couldn’t People Get a GLP-1? A 2023 U.S. Access Survey | Buy This GLP

A U.S. survey found that about half of respondents who tried to obtain GLP-1 medication reported being unable to get it in December 2023.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/why-cant-i-get-a-glp1-prescription
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Why Couldn’t People Get a GLP-1? A 2023 U.S. Access Survey

In a December 2023 U.S. survey, 49.9% of people who tried to obtain GLP-1 medication reported being unable to get it.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20268 min readUpdated November 2026

US adults, December 2023, self-reported · had heard of them · 81.6% · used one (eligible) · 13.4% · tried and failed to get one · 49.9% · The last bar is the one this desk exists for.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

A nationwide U.S. cohort asked adults about GLP-1 access in December 2023 (n = 4,555) [\[1\]](https://buythisglp.com/research/why-cant-i-get-a-glp1-prescription#ref-1). Our guide to [GLP-1 coverage by indication](https://buythisglp.com/research/does-insurance-cover-glp1) explains what to look for in a current plan. This survey recorded people’s experience at one point in time.

## What did people report?

Among respondents who tried to obtain medication, 49.9% reported that they did not get it. In the subgroup meeting the study’s weight-loss eligibility criteria (n = 1,883), those reporting healthcare access barriers had lower use (adjusted prevalence ratio 0.47, 95% CI 0.35–0.63) [\[1\]](https://buythisglp.com/research/why-cant-i-get-a-glp1-prescription#ref-1). The survey did not determine the reason for each failed attempt.

## What can I check for my situation?

A clinician can explain whether there is a prescribing option for your situation. If you get a quote, [compare the advertised price with the billed amount](https://buythisglp.com/research/glp1-headline-vs-billed-price) for the exact product and supply. Your current options may differ from what survey participants reported in 2023.

## Frequently asked

Did the survey explain each unsuccessful attempt?

It recorded reported access, eligibility and barriers. It could not determine why each person was unable to obtain treatment.

## Sources

1.  \[1\] Sanborn J, Fleary SA, Nash D, Penrose K, Parcesepe AM, Piltch-Loeb R (2026). GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort Annals of Epidemiology. [PMID 42349695](https://pubmed.ncbi.nlm.nih.gov/42349695/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
